Immunomodulation of malignant melanoma by contact sensitizing agents.
about
Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.Congenital malignant melanoma and cutaneous metastases treated with diphencyprone.
P2860
Immunomodulation of malignant melanoma by contact sensitizing agents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Immunomodulation of malignant melanoma by contact sensitizing agents.
@en
type
label
Immunomodulation of malignant melanoma by contact sensitizing agents.
@en
prefLabel
Immunomodulation of malignant melanoma by contact sensitizing agents.
@en
P2093
P2860
P1476
Immunomodulation of malignant melanoma by contact sensitizing agents.
@en
P2093
Devendra K Agrawal
Mario V Mitkov
Mark R Pittelkow
Ryan M Trowbridge
P2860
P356
10.1586/1744666X.2014.850415
P577
2013-11-22T00:00:00Z